Literature DB >> 3032260

Expression of human antithrombin III in Saccharomyces cerevisiae and Schizosaccharomyces pombe.

M Bröker, H Ragg, H E Karges.   

Abstract

Recombinant plasmids were constructed that direct the synthesis of human antithrombin III in baker's yeast, Saccharomyces cerevisiae, and the fission yeast, Schizosaccharomyces pombe. The signal sequence of antithrombin III was recognized by both yeast species, and antithrombin III was secreted into the medium. When the signal sequence was replaced by a sequence of ten arbitrary amino acids, the product expressed from such a construct stayed inside the cell. Antithrombin III was glycosylated by the baker's and fission yeast and was immunologically identical to antithrombin III isolated from human plasma. Antithrombin III isolated from the culture media of recombinant yeasts was biologically active, as could be shown by progressive inhibitor activity and heparin cofactor activity.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032260     DOI: 10.1016/0167-4781(87)90100-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Decreased affinity of recombinant antithrombin for heparin due to increased glycosylation.

Authors:  I Björk; K Ylinenjärvi; S T Olson; P Hermentin; H S Conradt; G Zettlmeissl
Journal:  Biochem J       Date:  1992-09-15       Impact factor: 3.857

2.  Transformation of Schizosaccharomyces pombe by electroporation.

Authors:  M T Hood; C Stachow
Journal:  Nucleic Acids Res       Date:  1990-02-11       Impact factor: 16.971

3.  Expression and Secretion of a Cellulomonas fimi Exoglucanase in Saccharomyces cerevisiae.

Authors:  C Curry; N Gilkes; G O'neill; R C Miller; N Skipper
Journal:  Appl Environ Microbiol       Date:  1988-02       Impact factor: 4.792

4.  Immobilization of the slime mould Dictyostelium discoideum for the continuous production of recombinant human antithrombin III.

Authors:  H Tiltscher; M Storr
Journal:  Appl Microbiol Biotechnol       Date:  1993-11       Impact factor: 4.813

Review 5.  Novel antithrombotic drugs in development.

Authors:  M Verstraete; P Zoldhelyi
Journal:  Drugs       Date:  1995-06       Impact factor: 9.546

6.  Elimination of glycosylation heterogeneity affecting heparin affinity of recombinant human antithrombin III by expression of a beta-like variant in baculovirus-infected insect cells.

Authors:  E Ersdal-Badju; A Lu; X Peng; V Picard; P Zendehrouh; B Turk; I Björk; S T Olson; S C Bock
Journal:  Biochem J       Date:  1995-08-15       Impact factor: 3.857

7.  Hepadnavirus infection requires interaction between the viral pre-S domain and a specific hepatocellular receptor.

Authors:  U Klingmüller; H Schaller
Journal:  J Virol       Date:  1993-12       Impact factor: 5.103

8.  Repeated batch cultivation of rBHK cells on Cytodex 3 microcarriers: antithrombin III, amino acid, and fatty acid metabolic quotients.

Authors:  G Schmid; H Zilg; R Johannsen
Journal:  Appl Microbiol Biotechnol       Date:  1992-12       Impact factor: 4.813

9.  Expression of the human blood coagulation protein factor XIIIa in Saccharomyces cerevisiae: dependence of the expression levels from host-vector systems and medium conditions.

Authors:  M Bröker; O Bäuml; A Göttig; J Ochs; M Bodenbenner; E Amann
Journal:  Appl Microbiol Biotechnol       Date:  1991-03       Impact factor: 4.813

10.  Expression of human antithrombin III in the cellular slime mould Dictyostelium discoideum.

Authors:  T Dingermann; E M Troidl; M Bröker; K Nerke
Journal:  Appl Microbiol Biotechnol       Date:  1991-07       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.